Publications

Generic Drug Law Update

February 2011
By: John Gherini, Michael Healy, Kelly Savage Day, Lenore Smith

In this edition:

• Justice Kagan and the Future of Generic Drug Preemption: U.S. Supreme Court Will Decide Fate of Preemption Defense for Generic Companies This Term
• Florida Appellate Court Holds Admissible Expert Testimony Rejected by Federal Courts in Zicam Suits
• CMS Continues the Deadline for Reporting Liability Settlements and Makes Other Changes That Could Affect Resolution of Product Liability Claims

View Original Source

Related People

Gherini, John
Healy, Michael F.
Savage Day, Kelly
Smith, Lenore C.

Related Offices

Ft. Lauderdale
San Francisco

Related Practices

Appellate

Complex Litigation

Life Sciences

Product Liability